Ilan Meshoulam

Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA.

Giza Venture Capital (Giza Venture) is a venture capital firm founded in 1992 by Zeev Holtzman and Zvi Schechter. The firm is headquartered in Tel Aviv, Israel.

Part of GE Aerospace, ELGEMS Ltd. is an Israeli company that designs and manufactures nuclear medicine imaging products. The company is based in Haifa, Israel. ELGEMS was acquired by GE Medical Systems, Inc. from Elbit Imaging Ltd. on January 02, 2001 for $30 million.

ChipX, Inc. designs and develops programmable application specific integrated circuits or Structured ASIC solutions. It offers PCI Express PHY, USB HS, and DDRII memory interfaces, as well as analog to digital and digital-to-analog converters. The company was founded in 1989 and is headquartered at Santa Clara, CA.

Biosense Webster, Inc. develops technology solutions for diagnosing heart rhythm disorders. It provides deflectable tip catheter for treating arrhythmia disorder. The company was founded by Wilton W. Webster Jr. and Shlomo Ben-Haim in 1998 and is headquartered in South Diamond Bar, CA.

Part of General Electric Co., GE Medical Systems Ceská Republika sro is a company based in Prague, Czechia. The Czech company distributes and services medical equipment.

Medingo Ltd. engages in developing a tiny insulin pump that allows people with diabetes to deliver insulin discreetly without tubing or injections. Medingo's product is Solo MicroPump. The company was founded on November 2, 2005 and is headquartered in Tel Aviv, Israel.

Van Leer Technology Ventures Jerusalem Ltd. (VLTVJ) is a leading Israeli high technology incubator and investment center which was formerly known as Docor-Shalem Technology Entrepreneurship Center Ltd. Established in 1992 by a consortium of sponsors including Intel, Teva Pharmaceuticals, AVX, Motorola and the Jerusalem Development Authority, VLTVJ aims to find and to foster entrepreneurs with high potential for creating successful technological companies. The firm is located in Jerusalem and is supported by their investors, Docor International BV and The Jerusalem Development Authority. They work with the office of the Chief Scientist within Israel's Ministry of Industry Trade and Employment, seeking to strengthen the Israeli economy and position Jerusalem as a leading city in the high-technology industry. VLTVJ embraces values that they believe reflect strong business practices and good citizenship and requires their investee companies to join them in 'doing good while doing well.'

UltraSPECT Ltd. supplies software products for the nuclear medicine imaging practices. It offers Xpress Cardiac a cardiac imaging product; Xpress3.Cardiac a product for three-minute myocardial perfusion SPECT and Xpress/Xact.Bone. The firm products are used in half-dose, half-time, quarter-time and gated scans cardiac applications as well as in attenuation correction cardiac applications. The company was founded by Israel Ohana, Shuli Cohen-Shwartz and Avi Elkayam in 1999 and is headquartered in Raanana, Israel.

Binational Industrial Research & Development Foundation was established by the U.S. and Israeli governments in 1977 to generate mutually beneficial cooperation between the private sectors of the U.S. and Israeli technology industries, including start-ups and established organizations. It provides both matchmaking services between U.S. and Israeli companies, as well as funding covering up to 50 percent of project development and product commercialization costs. The company is headquartered in Tel Aviv, Israel.

DigiFlex Ltd. develops UV-opaque mask for photopolymer plates. It offers FlexoJet 1725, inkjet-based computer-to-plate solution for photopolymer flexographic, letterpress, dry-offset, silk screen and pad printing technologies. The firm's solution consists of printing device, software, and a unique bi-component ink to create an opaque mask directly on top of the plate-replacing the need for film, image setter, and all of the chemical processing steps and equipment required for them. The company was founded by Uri Adler and Moshe Frenkel in 2005 and is headquartered in Kefar Sava, Israel.

Mekorot Water Co. Ltd. engages in the development of water resources and supply of water in Israel. Its services and solutions include desalination, drilling and hydrology, wastewater treatment and effluent reuse, and storm water catchment. The company was founded in 1937 and is headquartered in Tel Aviv, Israel.

The Israel National Nanotechnology Initiative provides federal program for engineering, science, and technology research. The company is headquartered in Tel Aviv, Israel.

NYU's agreement with the Emirate of Abu Dhabi to create NYU Abu Dhabi is the outcome of a shared understanding of the essential roles and challenges of higher education in the 21st century a common belief in the value of a liberal arts education, concurrence on the benefits a research university brings to the society that sustains it, a conviction that interaction with new ideas and people who are different is valuable and necessary, and a commitment to educating students who are true citizens of the world. NYU Abu Dhabi is a research university with a fully integrated liberal arts and science college. It draws students from around the world, and prepares them for the challenges and opportunities of its interconnected world. NYU Abu Dhabi equips students for leadership in all arenas of human endeavor. It fosters curiosity, creativity, and critical reflection. At NYU Abu Dhabi students extend themselves and the frontiers of knowledge. The residential life of students is central to the academic mission. Learning takes place across the campus, not only in classrooms, but also in residential houses, in clubs and sports, in informal campus gatherings, and in the wider community. NYU Abu Dhabi stimulates advanced research. The NYU Abu Dhabi Institute is a major research center. Research is integral to the undergraduate experience at NYU Abu Dhabi, and it also drives the university's graduate programs.

Real Imaging Ltd. develops imaging solution for breast cancer detection. It offers RUTH, a game-changing device for the detection of breast cancer; and Realimager3R, a non-invasive means for viewing and recording heat patterns generated by the human body. The company was founded in 2006 by Boaz Arnon and is headquartered in Lod, Israel.

Galooli Ltd. specializes in remote monitoring and management for optimizing energy usage. The company is based in Tel Aviv, Israel. The Israeli company's industrial IoT software provides visibility and insights to create value. The company also introduces and optimizes renewable energy technologies for facilities to reduce carbon footprint and fuel reliance. Galooli helps organizations improve efficiency and comply with standards for utilities management. The company was founded by Ronen Barel, Itamar Molchadsky, and Ronen Barel has been the CEO since incorporation.

Israel Advanced Technology Industries is an umbrella organization that represents the high-tech, life science, and other advanced technology industries. The private company is based in Hertzliya Pituach, Israel. The Israeli company was founded by Nechemia Jacob Peres, Aaron Mankovski, and Ruth Alon. The CEO is Karin Meir Rubinstein.

EyeYon Medical Ltd. engages in the development of medical devices for the treatment of corneal edema. Its products include hyperosmotic contact lens (Hyper-CL) for non-surgical treatment of corneal edema and DSPEK (descemet''s stripping pseudo endothelial keratoplasty) for replacing an injured endothelial layer, the cause of corneal edema, by an artificial endothelial layer. The company was founded by Daphna Ofer, Arie Marcovich and Nahum Ferera in 2010 and is headquartered in Jerusalem, Israel.

Bonfix Ltd. develops orthopedic implant to treat deformities. It engages in the development of an orthopedic implant to treat deformities related to Hallux Valgus (Bunions). The Bonfix implant offers a minimally invasive procedure to realign the 1st and 2nd metatarsals. The company was founded by Dror Robinsonin 2009 and is headquartered in Jerusalem, Israel.

Laryngoport Ltd. develops next generation platforms for laryngeal microsurgical procedures. Its tissue handling reduces the dental trauma and tissue damage produced by conventional rigid surgical tools and reduces time spent on positioning and exposure. The company was founded by Moshe Hain and Yonatan Lahav in 2012 and is headquartered in Jerusalem, Israel.

IOPtima Ltd. develops minimally-invasive surgical ophthalmic devices. The firm offers IOPtimate, a laser based surgical system to treat patients with primary open-angle glaucoma and pseudo-exfoliative glaucoma. Its IOPtimate utilizes a CO2 laser technology to reduce internal eye pressure by restoring the natural fluid percolation without penetrating into the eye. The company was founded in 2005 and is headquartered in Kiryat Atidim, Israel.

Colospan Ltd. operates as a clinical stage and medical device company that develops a technology for colorectal surgery to prevent the profound clinical and economic pains associated with colorectal anastomotic leaks and diverting stomas. The company was founded by Boaz Assaf in December 2010 and is headquartered in Kfar Saba, Israel.

Artsavit Ltd. develops cancer treatment drugs. It is developing small molecule ARTS mimetics designed to selectively induce apoptosis in cancer cells. The company was founded by Sarit Larisch in 2015 and is headquartered in Yavne, Israel.

SeaErra is an Israeli company that offers innovative underwater vision enhancement solutions based on state-of-the-art algorithms and technologies. The company was founded by Tali Treibitz and is currently based in Haifa, Israel. The company's AI-based solutions significantly improve visibility, contrast, and colors in real-time, and are compatible with a variety of cameras. The CEO is Nir Eliaz.

Ultrasight is an Israeli company that aims to revolutionize cardiac sonography through the power of machine learning to enable more accurate and timely clinical decisions. The company is based in Rehovot, Israel. The company's Ultrasight AI guidance system helps bring the benefits of cardiac imaging to more healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. Ultrasight has achieved CE marking for its real-time guidance software for cardiac ultrasound in the EU, and CA marking in the US. In 2020, Ultrasight won the TCT Innovation Competition, and in 2022, they won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most "innovative cardiac technology." Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. The company was founded by Achi Ludomirsky, Itay Kezurer, Yaron Lipman. Davidi Vortman has been the CEO of the company since 2020.